- ongoing, recruitingTherapeutic exploratory (Phase II)
A Multicenter, Randomized, Placebo-Controlled, Parallel Group Trial on the Safety and Efficacy of Istaroxime for Cardiogenic Shock SCAI Stage C (SEISMiC-C)
This study is testing a new medicine, Istaroxime, for people with a serious heart condition called cardiogenic shock. Researchers want to see if it's safe and helps improve blood pressure compared to a dummy medicine. It's an early-stage study to understand its effects better.
Poland · Czechia · Italy - recruiting
Improving Sedation Practice in Critically Ill Adult Patients Using a Co-designed Sedation Protocol
This study aims to improve how medication for pain and relaxation (sedation) is given to very ill patients on life support (ECMO). We want to create a new guide based on patient, family, and staff experiences to help these patients recover better.
United Kingdom - recruiting
Genomic Determinants of Outcome in Cardiogenic Shock
This study looks at people with a serious heart condition called cardiogenic shock. Researchers want to understand why some people respond differently to treatments by studying their genes and how their bodies react.
United Kingdom - not yet recruitingNA
Feasibility of Protocolised Analgosedation in ECMO
This study looks at whether a special plan for giving painkillers and sedatives (drugs to help you relax) to very sick patients on a life support machine called ECMO could lead to better long-term health. It's testing if such a study is possible to run.
United Kingdom